Company N4 Pharma Plc

ONZ

GB00BYW8QM32

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:01 2024-04-19 am EDT			5-day change	1st Jan Change
0.85 ^GBX	0.00%		+17.24%	0.00%

Apr. 18	N4 Pharma sees potential in Nuvec delivery method for cancer treatment	AN
Apr. 18	N4 Pharma’s In Vivo Testing Shows Nuvec’s Potential as Oral Delivery System	MT

N4 Pharma Plc is a United Kingdom-based specialist pharmaceutical company. The Company is focused on developing a silica nanoparticle delivery system to improve the cellular delivery of cancer treatments and vaccines. The Company is engaged in the development and commercialization of medicines through its delivery system, Nuvec. Nuvec is a silica nanoparticle technology with a patented spiky structure designed to load, protect and deliver nucleic acids (siRNA/DNA/mRNA) intracellularly for use in gene therapy, cancer therapeutics and vaccines. Nuvec is in the pre-clinical Phase, available for licensing to pharmaceutical and biotech partners for nucleic acid product development and is designed to overcome some of the drawbacks of existing delivery systems. The Companyâs wholly owned subsidiaries include N4 Pharma UK Limited.

Managers	Title	Age	Since
Nigel James Theobald FOU	Founder	59	13-12-31
David Templeton CTO	Chief Tech/Sci/R&D Officer	-	17-04-30

Members of the board	Title	Age	Since
Luke Sebastian Cairns BRD	Director/Board Member	46	20-07-13
Nigel James Theobald FOU	Founder	59	13-12-31
Chris Britten CHM	Chairman	-	19-05-19
David Templeton CTO	Chief Tech/Sci/R&D Officer	-	17-04-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	268,780,349	208,900,995 ( 77.72 %)	0	77.72 %

Name	Equities	%	Valuation
Mathenz Marc Kay 9.152 %	24,600,000	9.152 %	201 966 p
Nigel James Theobald 6.318 %	16,981,319	6.318 %	139 417 p
David Farrier 6.234 %	16,754,474	6.234 %	137 554 p
Luke Sebastian Cairns 0.0532 %	142,857	0.0532 %	1 173 p
John Chiplin 0.000000 %	0	0.000000 %	- p
Chris Britten 0.000000 %	0	0.000000 %	- p
David Templeton 0.000000 %	0	0.000000 %	- p

N4 Pharma Plc

Weston House Bradgate Park View

DE73 5UJ, Chellaston

+44 1332 690061

http://www.n4pharma.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
N4 PHARMA PLC	0.00%	2.84M
ELI LILLY AND COMPANY	+24.60%	654B
NOVO NORDISK A/S	+24.08%	552B
JOHNSON & JOHNSON	-5.63%	356B
MERCK & CO., INC.	+15.37%	319B
ABBVIE INC.	+7.38%	295B
ASTRAZENECA PLC	+3.26%	211B
NOVARTIS AG	+0.78%	206B
ROCHE HOLDING AG	-9.16%	197B
PFIZER, INC.	-9.69%	147B